Permisividad por posición | Próximas 5 jornadas desde J21 | Ordenado por facilidad
| # | Equipo | J21 | J22 | J23 | J24 | J25 | MEDIA |
|---|---|---|---|---|---|---|---|
| 1 |
BUR
|
BRE
|
AND
|
MUR
|
UNI
|
+5,3% | |
| 2 |
HIO
|
BUR
|
GIR
|
AND
|
MAN
|
+3,8% | |
| 3 |
AND
|
UNI
|
BUR
|
CAN
|
FCB
|
+1,8% | |
| 4 |
ZAR
|
GIR
|
BLB
|
BAS
|
RMA
|
-0,0% | |
| 5 |
CAN
|
COV
|
MUR
|
BRE
|
BAS
|
-1,3% | |
| 6 |
MAN
|
VBC
|
UNI
|
ZAR
|
HIO
|
-1,8% | |
| 7 |
BLB
|
BAS
|
ZAR
|
VBC
|
GCA
|
-3,4% | |
| 8 |
GIR
|
ZAR
|
CAN
|
FCB
|
BLB
|
-3,5% | |
| 9 |
COV
|
FCB
|
HIO
|
GCA
|
MUR
|
-3,9% | |
| 10 |
MUR
|
CAN
|
COV
|
BUR
|
BRE
|
-4,0% | |
| 11 |
UNI
|
AND
|
BAS
|
RMA
|
COV
|
-4,2% | |
| 12 |
BRE
|
JOV
|
RMA
|
UNI
|
ZAR
|
-5,0% | |
| 13 |
GCA
|
HIO
|
FCB
|
GIR
|
AND
|
-5,8% | |
| 14 |
BAS
|
RMA
|
JOV
|
COV
|
CAN
|
-9,5% | |
| 15 |
VBC
|
GCA
|
MAN
|
BLB
|
JOV
|
-10,9% | |
| 16 |
RMA
|
MUR
|
BRE
|
JOV
|
BUR
|
-11,1% | |
| 17 |
FCB
|
BLB
|
GCA
|
MAN
|
VBC
|
-11,4% | |
| 18 |
JOV
|
MAN
|
VBC
|
HIO
|
GIR
|
-11,7% |
| # | Equipo | J21 | J22 | J23 | J24 | J25 | MEDIA |
|---|---|---|---|---|---|---|---|
| 1 |
ZAR
|
GIR
|
BLB
|
BAS
|
RMA
|
+11,9% | |
| 2 |
AND
|
UNI
|
BUR
|
CAN
|
FCB
|
+9,7% | |
| 3 |
BUR
|
BRE
|
AND
|
MUR
|
UNI
|
+6,5% | |
| 4 |
GIR
|
ZAR
|
CAN
|
FCB
|
BLB
|
+5,1% | |
| 5 |
HIO
|
BUR
|
GIR
|
AND
|
MAN
|
+3,8% | |
| 6 |
MAN
|
VBC
|
UNI
|
ZAR
|
HIO
|
+3,1% | |
| 7 |
COV
|
FCB
|
HIO
|
GCA
|
MUR
|
+1,7% | |
| 8 |
RMA
|
MUR
|
BRE
|
JOV
|
BUR
|
-1,5% | |
| 9 |
BRE
|
JOV
|
RMA
|
UNI
|
ZAR
|
-6,0% | |
| 10 |
GCA
|
HIO
|
FCB
|
GIR
|
AND
|
-7,3% | |
| 11 |
MUR
|
CAN
|
COV
|
BUR
|
BRE
|
-8,2% | |
| 12 |
FCB
|
BLB
|
GCA
|
MAN
|
VBC
|
-8,9% | |
| 13 |
BLB
|
BAS
|
ZAR
|
VBC
|
GCA
|
-10,7% | |
| 14 |
BAS
|
RMA
|
JOV
|
COV
|
CAN
|
-10,7% | |
| 15 |
UNI
|
AND
|
BAS
|
RMA
|
COV
|
-10,9% | |
| 16 |
JOV
|
MAN
|
VBC
|
HIO
|
GIR
|
-11,5% | |
| 17 |
CAN
|
COV
|
MUR
|
BRE
|
BAS
|
-12,1% | |
| 18 |
VBC
|
GCA
|
MAN
|
BLB
|
JOV
|
-16,2% |
| # | Equipo | J21 | J22 | J23 | J24 | J25 | MEDIA |
|---|---|---|---|---|---|---|---|
| 1 |
HIO
|
BUR
|
GIR
|
AND
|
MAN
|
+6,3% | |
| 2 |
CAN
|
COV
|
MUR
|
BRE
|
BAS
|
+6,3% | |
| 3 |
BUR
|
BRE
|
AND
|
MUR
|
UNI
|
+4,9% | |
| 4 |
GIR
|
ZAR
|
CAN
|
FCB
|
BLB
|
+1,0% | |
| 5 |
MUR
|
CAN
|
COV
|
BUR
|
BRE
|
-0,5% | |
| 6 |
GCA
|
HIO
|
FCB
|
GIR
|
AND
|
-0,8% | |
| 7 |
AND
|
UNI
|
BUR
|
CAN
|
FCB
|
-1,5% | |
| 8 |
BLB
|
BAS
|
ZAR
|
VBC
|
GCA
|
-2,5% | |
| 9 |
ZAR
|
GIR
|
BLB
|
BAS
|
RMA
|
-3,4% | |
| 10 |
MAN
|
VBC
|
UNI
|
ZAR
|
HIO
|
-5,4% | |
| 11 |
UNI
|
AND
|
BAS
|
RMA
|
COV
|
-5,6% | |
| 12 |
COV
|
FCB
|
HIO
|
GCA
|
MUR
|
-7,4% | |
| 13 |
BRE
|
JOV
|
RMA
|
UNI
|
ZAR
|
-8,2% | |
| 14 |
VBC
|
GCA
|
MAN
|
BLB
|
JOV
|
-13,1% | |
| 15 |
JOV
|
MAN
|
VBC
|
HIO
|
GIR
|
-13,3% | |
| 16 |
RMA
|
MUR
|
BRE
|
JOV
|
BUR
|
-14,9% | |
| 17 |
BAS
|
RMA
|
JOV
|
COV
|
CAN
|
-16,3% | |
| 18 |
FCB
|
BLB
|
GCA
|
MAN
|
VBC
|
-17,6% |
| # | Equipo | J21 | J22 | J23 | J24 | J25 | MEDIA |
|---|---|---|---|---|---|---|---|
| 1 |
BUR
|
BRE
|
AND
|
MUR
|
UNI
|
+4,6% | |
| 2 |
UNI
|
AND
|
BAS
|
RMA
|
COV
|
+3,9% | |
| 3 |
BLB
|
BAS
|
ZAR
|
VBC
|
GCA
|
+2,9% | |
| 4 |
CAN
|
COV
|
MUR
|
BRE
|
BAS
|
+2,0% | |
| 5 |
HIO
|
BUR
|
GIR
|
AND
|
MAN
|
+1,3% | |
| 6 |
BRE
|
JOV
|
RMA
|
UNI
|
ZAR
|
-0,8% | |
| 7 |
BAS
|
RMA
|
JOV
|
COV
|
CAN
|
-1,3% | |
| 8 |
AND
|
UNI
|
BUR
|
CAN
|
FCB
|
-2,7% | |
| 9 |
MAN
|
VBC
|
UNI
|
ZAR
|
HIO
|
-3,1% | |
| 10 |
MUR
|
CAN
|
COV
|
BUR
|
BRE
|
-3,4% | |
| 11 |
VBC
|
GCA
|
MAN
|
BLB
|
JOV
|
-3,5% | |
| 12 |
COV
|
FCB
|
HIO
|
GCA
|
MUR
|
-5,9% | |
| 13 |
FCB
|
BLB
|
GCA
|
MAN
|
VBC
|
-7,8% | |
| 14 |
ZAR
|
GIR
|
BLB
|
BAS
|
RMA
|
-8,6% | |
| 15 |
GCA
|
HIO
|
FCB
|
GIR
|
AND
|
-9,2% | |
| 16 |
JOV
|
MAN
|
VBC
|
HIO
|
GIR
|
-10,4% | |
| 17 |
GIR
|
ZAR
|
CAN
|
FCB
|
BLB
|
-16,6% | |
| 18 |
RMA
|
MUR
|
BRE
|
JOV
|
BUR
|
-16,9% |

















